Eighty Mardiyan Kurniawati and Nur Anisah Rahmawati and Anna SurgeanVeterini (2021) Considering Role of Probiotic on Respiratory Disease: Is Probiotic Possible to Treat COVID-19? Indian Journal of Forensic Medicine & Toxicology,, 15 (2). pp. 4003-4008. ISSN 9739122

	Text (Artikel) 19. Artikel 80.pdf Download (800kB)
	Text (Kualitas Karil & Kesesuaian Bidang Ilmu) 19. Karil.pdf Download (265kB)
	Text (Bukti Korespondensi) 19. Korespondensi.pdf Download (343kB)
	Text (Turnitin) 19.turnitin.pdf Download (1MB)

Abstract

Abstract Background: COVID-19 is a new variant of the corona virus known as a pandemic disease. The number of cases has increased every day around the world. Unfortunately, treatment in management has not been satisfactory. Purpose: This study aims to examine the role of probiotics in respiratory disease and the possibility of managing COVID-19 through an analysis of its function. Method: This study is a review. Quality journals until 2020 were searched in the Pubmed database for the keywords ‘respiratory’ or ‘asthma’ or ‘pneumonia’ or ‘lung’ or ‘influenza’ and ‘COVID-19’. Compiled data includesthe author, type of study, type of probiotic, duration of intervention, target population, results, conclusion and side effects that occurred Results: We analyzed 9 experimental studies. Some studies related to respiratory disorders used the Lactobacillus Sp as probiotic. One research used Fructooligosacharide as additional ingredient. The research use different doses and timing of interventions 14 days - 6 months. The diseases covered in this report are asthma, pneumonia, and influenza. Probiotics can reduce symptomps, duration in hospitality risk, and quality of life. Conclusion: The ability of probiotics in the management of respiratory diseases provides hope for the management of COVID-19, of course, it is balanced with further research that is able to analyze clear dosages, types and roles.

Actions (login required)

View Item